FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

1522851000168107: glucose 250 g / 2.566 L injection, 1.316 L chamber (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4519021000168117 glucose 250 g / 2.566 L injection, 1.316 L chamber (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4519031000168119 glucose 250 g/2.566 L injection, 1.316 L chamber en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
glucose 250 g/2.566 L injection, 1.316 L chamber Is a glucose true Inferred relationship Some
glucose 250 g/2.566 L injection, 1.316 L chamber Is a medicinal product unit of use true Inferred relationship Some
glucose 250 g/2.566 L injection, 1.316 L chamber has manufactured dose form injection true Inferred relationship Some
glucose 250 g/2.566 L injection, 1.316 L chamber has intended active ingredient glucose true Inferred relationship Some 1314456562
glucose 250 g/2.566 L injection, 1.316 L chamber has Australian BoSS glucose true Inferred relationship Some 1314456562
glucose 250 g/2.566 L injection, 1.316 L chamber has unit of use chamber true Inferred relationship Some 1131560206
Inbound Relationships Type Active Source Characteristic Refinability Group
Kabiven G19% Glucose 250 g/2.566 L injection, 1.316 L chamber Is a True glucose 250 g/2.566 L injection, 1.316 L chamber Inferred relationship Some
glucose 250 g/2.566 L injection [1.316 L chamber] (&) alanine 12 g/2.566 L + arginine 8.5 g/2.566 L + aspartic acid 2.6 g/2.566 L + glutamic acid 4.2 g/2.566 L + glycine 5.9 g/2.566 L + histidine 5.1 g/2.566 L + isoleucine 4.2 g/2.566 L + leucine 5.9 g/2.566 L + lysine hydrochloride 8.5 g/2.566 L + methionine 4.2 g/2.566 L + phenylalanine 5.9 g/2.566 L + proline 5.1 g/2.566 L + serine 3.4 g/2.566 L + threonine 4.2 g/2.566 L + tryptophan 1.4 g/2.566 L + tyrosine 170 mg/2.566 L + valine 5.5 g/2.566 L + calcium chloride dihydrate 740 mg/2.566 L + sodium glycerophosphate 3.8 g/2.566 L + magnesium sulfate heptahydrate 2.5 g/2.566 L + potassium chloride 4.5 g (potassium 60 mmol)/2.566 L + sodium acetate trihydrate 6.1 g/2.566 L injection [750 mL chamber] (&) soya oil 100 g/2.566 L injection [500 mL chamber], 2.566 L multi-chamber bag has MPUU True glucose 250 g/2.566 L injection, 1.316 L chamber Inferred relationship Some 713382068
glucose 250 g/2.566 L injection [1.316 L chamber] (&) alanine 12 g/2.566 L + arginine 8.5 g/2.566 L + aspartic acid 2.6 g/2.566 L + glutamic acid 4.2 g/2.566 L + glycine 5.9 g/2.566 L + histidine 5.1 g/2.566 L + isoleucine 4.2 g/2.566 L + leucine 5.9 g/2.566 L + lysine hydrochloride 8.5 g/2.566 L + methionine 4.2 g/2.566 L + phenylalanine 5.9 g/2.566 L + proline 5.1 g/2.566 L + serine 3.4 g/2.566 L + threonine 4.2 g/2.566 L + tryptophan 1.4 g/2.566 L + tyrosine 170 mg/2.566 L + valine 5.5 g/2.566 L + calcium chloride dihydrate 740 mg/2.566 L + sodium glycerophosphate 3.8 g/2.566 L + magnesium sulfate heptahydrate 2.5 g/2.566 L + potassium chloride 4.5 g (potassium 60 mmol)/2.566 L + sodium acetate trihydrate 6.1 g/2.566 L injection [750 mL chamber] (&) soya oil 100 g/2.566 L injection [500 mL chamber], 3 x 2.566 L multi-chamber bags has MPUU True glucose 250 g/2.566 L injection, 1.316 L chamber Inferred relationship Some 362463242

Reference Sets

Medicinal product unit of use reference set

Back to Start